Raanana, Israel - Polyrizon Ltd. (NASDAQ:PLRZ), a biotech firm in the development stage, has filed a divisional patent application in Israel for its Trap & Target (NYSE:TGT) (T&T) platform technology.
Polyrizon Ltd. (Nasdaq: PLRZ) (the “Company” or “Polyrizon”), a development-stage biotech company specializing in the development of innovative intranasal hydrogels, today announced the filing of a ...
Eurofins CDMO Amatsiaquitaine S.A.S., the GMP manufacturer, to support Polyrizon in future commercialization efforts Raanana, Israel, Jan. 23, 2025 (GLOBE NEWSWIRE) -- Polyrizon Ltd. (the "Company" or ...
LTR Pharma said the nasal cavity was a highly vascular part of the body supporting even and rapid absorption of the drug. Results of a pivotal trial showed a 470% faster absorption than oral ...
Stuffy, sneezing, miserable: folks plagued by chronic sinusitis know the feeling all too well. Experts at University of Cincinnati Health say it's also an all-too-common affliction, affecting an ...